LDX lumos diagnostics holdings limited

Ann: Q3 FY25 Investor Briefing, page-3

  1. 235 Posts.
    lightbulb Created with Sketch. 86
    Answered both questions in final slide =

    "implement strategies to maintain and improve the rate of bacterial postive patients enrolled" suggests its actually a problem having a lower amount of bacterial prevalence and that they need more of them to support the the CLIA submission. If so, means an extended testing period whilst they address this issue and come up with a plan, and then get more "useful" patients to test.

    Thats my reading of it anyway :-(
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.2¢
Change
-0.001(1.37%)
Mkt cap ! $53.89M
Open High Low Value Volume
7.3¢ 7.4¢ 7.2¢ $258.9K 3.538M

Buyers (Bids)

No. Vol. Price($)
2 10491 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 455183 2
View Market Depth
Last trade - 12.20pm 31/07/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.